4//SEC Filing
Burgess Justin 4
Accession 0001209191-24-003544
CIK 0001029142other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:42 PM ET
Size
14.2 KB
Accession
0001209191-24-003544
Insider Transaction Report
Form 4
Burgess Justin
VP Finance & CAO
Transactions
- Exercise/Conversion
Common Stock
2024-02-16+6,667→ 15,803 total - Tax Payment
Common Stock
2024-02-16$12.41/sh−2,378$29,511→ 13,425 total - Exercise/Conversion
Restricted Stock Unit
2024-02-16−6,667→ 13,333 total→ Common Stock (6,667 underlying) - Award
Stock Options (Right to Buy)
2024-02-15+13,500→ 13,500 totalExercise: $12.48Exp: 2031-02-15→ Common Stock (13,500 underlying) - Award
Restricted Stock Unit
2024-02-15+21,900→ 21,900 total→ Common Stock (21,900 underlying)
Footnotes (7)
- [F1]Code M: Exercise or conversion of derivative security
- [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 16, 2023.
- [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
- [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
- [F5]Code A: Grant, award or other acquisition
- [F6]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
- [F7]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001812025
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:42 PM ET
- Size
- 14.2 KB